Correlation Between YS Biopharma and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both YS Biopharma and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YS Biopharma and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YS Biopharma Co, and Immix Biopharma, you can compare the effects of market volatilities on YS Biopharma and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YS Biopharma with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of YS Biopharma and Immix Biopharma.
Diversification Opportunities for YS Biopharma and Immix Biopharma
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between YS Biopharma and Immix is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding YS Biopharma Co, and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and YS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YS Biopharma Co, are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of YS Biopharma i.e., YS Biopharma and Immix Biopharma go up and down completely randomly.
Pair Corralation between YS Biopharma and Immix Biopharma
Allowing for the 90-day total investment horizon YS Biopharma Co, is expected to under-perform the Immix Biopharma. In addition to that, YS Biopharma is 1.1 times more volatile than Immix Biopharma. It trades about -0.02 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.03 per unit of volatility. If you would invest 205.00 in Immix Biopharma on August 27, 2024 and sell it today you would lose (26.00) from holding Immix Biopharma or give up 12.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 77.48% |
| Values | Daily Returns |
YS Biopharma Co, vs. Immix Biopharma
Performance |
| Timeline |
| YS Biopharma Co, |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Immix Biopharma |
YS Biopharma and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with YS Biopharma and Immix Biopharma
The main advantage of trading using opposite YS Biopharma and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YS Biopharma position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| YS Biopharma vs. Revelation Biosciences | YS Biopharma vs. Cardio Diagnostics Holdings | YS Biopharma vs. Biodexa Pharmaceticals | YS Biopharma vs. ZyVersa Therapeutics |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |